Skip to content
Search

Latest Stories

Boost for vaccine doses planned for poor as virus rages on

Up to 100 million additional doses of any eventual Covid-19 vaccines will be secured for delivery to poorer countries in 2021, health groups announced on Tuesday (29), as the virus showed no sign of receding after claiming more than one million lives around the world.

The announcement doubles the number of doses already secured from the Serum Institute of India by the Gavi vaccine alliance and the Bill & Melinda Gates Foundation, following an initial agreement last month.


The public-private health partnership stressed that the eventual total is "potentially several times" greater, and said the price would be capped at $3 per dose.

"No country, rich or poor, should be left at the back of the queue when it comes to Covid-19 vaccines; this collaboration brings us another step closer to achieving this goal," Gavi chief Seth Berkley said in a statement.

As nine vaccine candidates are in last-stage trials, the World Health Organization is stepping up efforts to provide faster and cheaper testing to poorer countries.

The WHO said Monday that some 120 million rapid tests for Covid-19 will be made available to low- and middle-income countries at $5 each under a $600 million scheme -- as long as funding can be secured.

The kits -- faster, cheaper and easier to administer than regular standard polymerase chain reaction (PCR) swab tests, but also less reliable -- will be rolled out across 133 countries in the next six months.

"This will enable the expansion of testing, particularly in hard-to-reach areas that do not have lab facilities or enough trained health workers to carry out PCR tests," WHO director-general Tedros Adhanom Ghebreyesus told a virtual press conference.

Experts have for months been calling for widespread adoption of this low-cost technology so that people can test themselves several times a week.

In the US, President Donald Trump said 150 million tests would be distributed that deliver results in 15 to 30 minutes.

Harvard epidemiologist Michael Mina said the testing drive "is terrific and is a great start".

But the amount being distributed by the US government was "simply not sufficient" and production should be multiplied ten- or 20-fold, he added

- European wave -

Meanwhile infection numbers are climbing rapidly in Europe whose governments are clamping down on movement in an attempt to curb the surge.

Paris, London, Madrid have all been forced to introduce controls to slow infections, and Northern Ireland authorities became the latest to tighten curbs, while the Czech Republic and Slovakia said they were preparing to declare a state of emergency.

A million Madrid residents are under partial lockdown, with the city and the surrounding region at the centre of Spain's second wave.

The national government on Monday warned the local authorities of drastic measures if the region failed to move decisively to slow the uncontrolled spread.

Meanwhile, in Greece the first cruise ship to sail to the country since its lockdown docked at the port of Piraeus after a dozen crew members were reported positive for the virus.

Passengers underwent follow-up coronavirus tests, with early results negative.

In Israel, which has the world's highest infection rate per capita, Health Minister Yuli Edelstein said Tuesday that there was "no way" the country's second nationwide coronavirus lockdown would be lifted after three weeks as originally planned.

WHO chief Ghebreyesus said that coronavirus could still be effectively contained with measures such as social distancing and handwashing.

"One million people have now been lost to Covid-19 and many more are suffering because of the pandemic," Tedros said in an article in the British online newspaper The Independent.

"This milestone is a difficult moment for the world but there are glimmers of hope that encourage us now and in the near future.

"No matter where a country is in an outbreak, it is never too late to turn things around."

- 'Never too late' -

Worldwide the virus has now infected more than 33 million people and killed over a million, according to an AFP tally compiled from official sources.

Mid-September saw a record rise in cases in most regions and the WHO has warned that virus deaths could even double to two million without more global collective action.

On Monday the number of cases in India surpassed six million, with the country on course to overtake the United States in the coming weeks as the nation with the most infections.

More For You

Shefali Jariwala

Glutathione and anti ageing drugs under spotlight after Shefali Jariwala death

Instagram/shefalijariwala

Did anti-ageing pills, beauty supplements and glutathione trigger Shefali Jariwala’s death?

Quick highlights:

  • Shefali Jariwala died at 42 in Mumbai after reportedly collapsing post-fast; cause of death suspected to be cardiac arrest or blood pressure drop.
  • Police found anti-ageing pills, vitamin supplements, and glutathione injections at her residence.
  • Doctors stress the risks of unsupervised use of hormone-based and anti-ageing treatments.
  • Final post-mortem report expected in two days; no foul play suspected, case treated as accidental death.

The untimely death of actor-model Shefali Jariwala has sparked renewed concern over the unregulated use of anti-ageing treatments and self-medication. The 42-year-old, best known for her appearance in Kaanta Laga, was declared dead on arrival at a Mumbai hospital on Friday night. Initial investigations suggest she may have suffered a cardiac arrest following a steep drop in blood pressure, possibly linked to taking supplements on an empty stomach.

Keep ReadingShow less
Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less